Colorimetric field drug test working group - creation - members - duties - report - repeal

2-2-2401. Colorimetric field drug test working group - creation - members - duties - report - repeal. (1) (a) Notwithstanding section 2-3-303.3, there is created the working group to make findings and recommendations concerning the use of colorimetric field drug tests in the various stages of criminal proceedings and in carceral settings. (b) (I) (A) On or before June 13, 2025, the director of the legislative council shall use a request for proposal process to contract with and designate a nonprofit organization to provide staffing and facilitate the performance of the working group's duties pursuant to this part 24, subject to the approval of the chair of the executive committee of the legislative council. (B) The duties required in this part 24 are contingent on awarding a contract and designating a nonprofit organization pursuant to this subsection (1)(b). If a contract is not awarded and a nonprofit organization is not designated to provide staffing and facilitate the performance of the working group's duties required pursuant to this part 24, then none of the provisions of this part 24 are required to occur. (II) It is the intent of the general assembly that no general fund money be appropriated for a contract with the nonprofit organization for the nonprofit organization to provide staffing and facilitate the performance of the working group's duties pursuant to this part 24. The nonprofit organization is solely responsible for the costs of providing the contracted services, providing staffing, and facilitating the performance of the working group's duties pursuant to this part 24. The nonprofit organization may accept monetary or in-kind gifts, grants, and donations to defray the costs of providing the contracted services, providing staffing, and facilitating the performance of the working group's duties pursuant to this part 24. (2) (a) The working group consists of: (I) One member of the majority party of the house of representatives, appointed by the speaker of the house of representatives, who shall serve as chair; (II) One member of the minority party of the senate, appointed by the president of the senate, who shall serve as vice-chair; (III) One member of the house of representatives, appointed by the speaker of the house of representatives; (IV) The attorney general or their designee; (V) The director of the Colorado bureau of investigation or their designee; (VI) One member who represents an organization that works to exonerate people who were wrongfully convicted, appointed by the speaker of the house of representatives; (VII) The state public defender or their designee; (VIII) One member who represents the Colorado criminal defense bar, appointed by the speaker of the house of representatives; (IX) One member who represents the alternate defense counsel, appointed by the speaker of the house of representatives; (X) The executive director of the Colorado district attorneys' council or their designee; (XI) The president of the county sheriffs of Colorado or their designee; (XII) The president of the Colorado association of chiefs of police or their designee; (XIII) The president of the Colorado fraternal order of police or their designee; (XIV) The executive director of the department of corrections or their designee; (XV) One member who is an instructor at an institution of higher education in Colorado and has expert knowledge of, and research experience with, forensic science, appointed by the president of the senate; (XVI) One member who is a person who was impacted by a false positive test result from the use of a colorimetric field drug test, or their designee, appointed by the speaker of the house of representatives; and (XVII) One member who is a national expert on wrongful convictions caused by the use of colorimetric field drug tests, appointed by the speaker of the house of representatives. (b) The appointing authority shall make appointments to the working group no later than July 1, 2025. (c) Beginning in July of 2025, the working group shall meet three times using audio-visual communication technology and shall complete its duties no later than December 1, 2025. (d) Members serve at the pleasure of their respective appointing authorities. If a vacancy occurs, the appropriate appointing authority shall promptly appoint a new member who satisfies the membership requirement of the vacated seat. (e) Members serve without compensation but may be reimbursed for expenses directly relating to their service to the working group. (3) The working group shall make: (a) Findings concerning the prevalence and circumstances when colorimetric field drug tests are used in the various stages of criminal proceedings and in carceral settings; (b) Findings concerning the potential harms that result from using colorimetric field drug tests in the various stages of criminal proceedings and in carceral settings, including the potential for unjust pretrial detention, coercive guilty pleas, and wrongful convictions; (c) Findings and recommendations for legislation or policy solutions to eliminate harms from the use of colorimetric field drug tests in the various stages of criminal proceedings and in carceral settings; and (d) Findings and recommendations for legislation or alternative policy solutions concerning using colorimetric field drug tests for presumptive purposes only in the various stages of criminal proceedings and in carceral settings, including collateral consequences, in order to prevent future harms. (4) The working group shall not recommend bill drafts as part of its recommendations. (5) The working group may collaborate with any person or entity that the working group deems appropriate to assist the working group in performing its duties pursuant to this section. A state entity that is requested to provide assistance to the working group in performing its duties shall assist the working group, to the extent the assistance provided by the state entity is consistent with the state entity's duties and law. At a minimum, the state entity must provide to the working group, upon request, any existing information regarding the prevalence and circumstances when colorimetric field drug tests are used and any existing policies concerning the use of colorimetric field drug tests. (6) On or before December 1, 2025, the working group shall report its findings and recommendations to the judiciary committees of the house of representatives and senate, or any successor committees. At a minimum, the report must include the working group's findings and recommendations required pursuant to subsection (3) of this section. (7) This section is repealed, effective July 1, 2026. Source: L. 2025: Entire part added, (HB 25-1183), ch. 349, p. 1881, � 2, effective June 2. PART 25 LEGISLATION INSIDE ADVISORY COUNCIL